It certainly does have a place, Northern, and it may have in this case and the judge has left a decision for two days so that all sides can speak and hopefully reach an agreement before he must rule on it.
Screaming, IMO, and it's just my opinion, Neuroblastoma Alliance is an excellent paediatric charity. The Brain Tumour Charity, Leukaemia and Lymphoma Research and The Aila Coull Foundation, which has just been set up as charity status, so see their page on FB, is exclusively dedicated to research into paediatric AML (Aila was a 16-month-old baby in Aillidh's unit whose mutations would have required bone marrow transplant, but she was unable to be remitted with the chemo available and died), are good ones.
Cancer Research UK dedicates very little of its takings into research of specifically paediatric cancers, or cancers which largely target children and teens, such as Ewing's sarcoma, osteosarcoma, retinoblastoma and neuroblastoma, although apparently it has been able to grant funding into a new drug that will hopefully pass trials to treat AML (AML is the most common form of leukaemia in adults) (the past two drugs designed failed in the last stage of trial). Many afflicted with AML, however, die from the chemo protocol, as it is one of the harshest, and those whose mutations require stem cell/bone marrow transplant present with rather shocking overall (OS) survival rates), particularly as many diagnosed are 'elderly', over 55.
Worldwide AML chemo protocol, including for children, involves 3-4 rounds of 7-10 days of treatment of 3-4 chemotherapy drugs delivered via Hickman/central line in a strict hospital setting. No oral, no day unit, no going home. The treatment causes rapid depletion of all immune system excepting lymphocyte (AML is a cancer of the granulocytes), so the patient is usually, from about the 4th-5th day of treatment, confined to strict isolation.
The goal is to annihilate pretty much all of the immune system, as theirs is a cancer of it.
The drug GCS-F is normally not used unless the patient has failed protocol and needs to have his/her blood cell counts induced to rise to be knocked out with more chemo. Instead, it is strict iso and blood and platelet transfusions until blood cell counts rise enough for the next round of chemo to begin.
Those who are 'lucky', and do not present with mutations requiring stem cell/bone marrow transplant or do not die from infection following chemo usually remain in hospital entirely from 6-8 months.
Those who are not so fortunate face a 5th and further round of chemo IF they remit, a conditioning round to allow them to take stem cell/bone marrow transplant. Since many forms of AML requiring stem cell/bone marrow transplant have a very high (50-85%) risk of relapse, protocol is that attempt to transplant must take place following clear cytogenetics of bone marrow aspirate within 12 weeks of the last course of chemo. If possible, a harvest of the patient's own bone marrow is taken as backup and to donate to medical research upon their death should the parent or patient consent (we did. Our daughter had an absolutely cracking harvest, cancer free, of 500mL of fluid).
This 5th round is 7 days long. Consensus at a conference in Geneva of clinical study was that chemo drug treatment was on par with chemo + total body irradiation/radiotherapy, and A's own consultant recognised that radiotherapy can come with as many if not more problems as chemo itself.
It consists of 4 drugs given via central line and completely eradicates the immune system, including lymphocytes.
If the patient develops infection before the graft takes, a not insignificant likelihoood, the chance of death grows.
Aillidh fell into this. She had a very common infection known as human metapneumo virus that migrated from her throat into her lungs. She also had a bacterial infection call psuedomonas that migrated from her gut into her lungs, probably through vomitting. These two infections inhibited engraftment. She then developed graft v. host disease, the only treatment for which is steroids, which worsened everythign in her lungs. And as she had no immune system she didn't respond well to antibiotics and the antivirals available suppress bone marrow function.
The upshot is that by the time her body was able to be on the road to defeating these infections and engrafted, her lungs were so damaged that she died.
This has to stop.
Same way treatment for brain tumours has to get better.
Has to.
Yes, radiotherapy has a place, and it may do in this case and hopefully an agreement can be reached.
But people, there has to be a better way, for all these children.
I don't know what type of brain cancer little Neon has. But there are some of them for which precious little can be done and not without grave consequence.
This isn't some hippy nutter. This is a mother with serious questions about her son's health and treatment.
I can't judge her. We only did what we did hoping Aillidh would be in that 19% of paediatric AMLs with FLT3 mutation who live. She wasn't.
I don't stand to judge a parent in a similar spot.